NIT
ARNA

NumerixS Investment Technologies’s Arena Pharmaceuticals Inc ARNA Stock Holding History

NumerixS Investment Technologies’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,400
Closed -$284K – 1437
2019
Q1 		$284K Buy
6,400
+4,075
+175% +$187K 0.04% 551
2018
Q4 		$90K Buy
2,325
+700
+43% +$27.5K 0.03% 599
2018
Q3 		$70K Sell
1,625
-1,875
-54% -$76K 0.01% 897
2018
Q2 		$148K Sell
3,500
-800
-19% -$34.4K 0.03% 624
2018
Q1 		$170K Buy
+4,300
New +$167K 0.04% 465
2015
Q1 		– Sell
-6,197
Closed -$215K – 719
2014
Q4 		$215K Buy
+6,197
New +$252K 0.07% 397

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

NumerixS Investment Technologies's ARNA Position: Q2 2019 in Review

NumerixS Investment Technologies sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 6,400 shares — an estimated $284K sold.

NumerixS Investment Technologies first reported a position in ARNA in Q4 2014 and held it in 6 quarters. The position peaked at $284K in Q1 2019. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

  • NumerixS Investment Technologies reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 6,400 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $284K.
  • NumerixS Investment Technologies first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 6 quarters.
  • NumerixS Investment Technologies's Arena Pharmaceuticals Inc position peaked at $284K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on NumerixS Investment Technologies's 13F filing for Q2 2019, filed 13 Aug 2019.